UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622

2015

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486

2022

Link zum Volltext

Verfügbarkeit prüfen

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Journal of clinical oncology, 2012-07, Vol.30 (19), p.2327-2333

2012

Link zum Volltext

Verfügbarkeit prüfen

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

JNCI : Journal of the National Cancer Institute, 2022-03, Vol.114 (3), p.427-435

2022

Link zum Volltext

Verfügbarkeit prüfen

In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19

Diabetes/metabolism research and reviews, 2020-10, Vol.36 (7), p.e3331-n/a

Blanke, Charles D.

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3605-3610

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1693-1704

2021

Link zum Volltext

Verfügbarkeit prüfen

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2020-2028

2023

Link zum Volltext

Verfügbarkeit prüfen

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8664-8670

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4922-4927

2006

Link zum Volltext

Verfügbarkeit prüfen

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4555-4560

2011

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414)

Journal of thoracic oncology, 2012-05, Vol.7 (5), p.906-912

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2781-2786

2011

Link zum Volltext

Verfügbarkeit prüfen

The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2007-01, Vol.12 (1), p.38-50

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Clinical cancer research, 2020-05, Vol.26 (10), p.2290-2296

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1217-1227

2019

Link zum Volltext

Verfügbarkeit prüfen

The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials

JAMA oncology, 2016-07, Vol.2 (7), p.875

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

Journal of clinical oncology, 2019-08, Vol.37 (22), p.1876-1885

2019

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers in GIST: Partly Ready for Prime-Time Use

Clinical cancer research, 2009-09, Vol.15 (18), p.5603-5605

Blanke, Charles D

2009

Link zum Volltext

Verfügbarkeit prüfen

Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set

Journal of clinical oncology, 2010-01, Vol.28 (3), p.460-465

2010

Link zum Volltext

Verfügbarkeit prüfen

Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships

Clinical cancer research, 2024-01, Vol.30 (1), p.29

2024

Link zum Volltext

Verfügbarkeit prüfen

Safeguards for medical aid in dying

British journal of hospital medicine (London, England : 2005), 2024-02, Vol.85 (2), p.1

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials

Journal of clinical oncology, 2006-01, Vol.24 (1), p.141-144

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort

Cancer, 2021-09, Vol.127 (17), p.3194-3201

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1695-1703

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 273

Suche als RSS-Feed

Aktive Filter

ThemaImatinib Mesylate

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(249)

Publikationsform

Artikel
(166)
Buchkapitel
(101)
Bücher
(3)
Reviews
(2)
Berichte
(1)

Sprache

Englisch
(272)
Japanisch
(15)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(117)
Science & Technology
(117)
Humans
(113)
Oncology
(112)
Female
(65)
Male
(63)
Middle Aged
(59)
Aged
(55)
Adult
(43)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Chemotherapy
(29)
Tumors
(29)
Aged, 80 And Over
(28)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Treatment Outcome
(24)
Cancer
(19)
Cancer Research
(19)
Colorectal Neoplasms - Drug Therapy
(19)
Disease-Free Survival
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(30)
Cancer
(13)
Clinical Cancer Research
(11)
Jama Oncology
(9)
Cancer Research
(7)
Clinical Colorectal Cancer
(6)
Jama Network Open
(6)
Jnci : Journal Of The National Cancer Institute
(5)
Oncology
(5)
Southern Medical Journal
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414)

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

Biomarkers in GIST: Partly Ready for Prime-Time Use

Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set

Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships

Safeguards for medical aid in dying

Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials

A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

Aktive Filter

Suchergebnisse filtern